Transcripts StemRIM

Stocks

Delayed Japan Exchange Other stock markets 09:30:00 17/07/2026 +03			5-day change	1st Jan Change
294.00 ^JPY	-1.01%		-6.96%	+11.79%

07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI
06-17	StemRIM Announces Patent Registration for Redasemtide, as an Additional Therapeutic Indication of Cartilage Disorders	CI